Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
Quick Stats
Jan 30, 202651.0
AI Score
HOLD0.31
Volume Ratio
Mar 19, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
GANX Stock Summary
Last updated Jan 30, 2026
GANX is currently trading at $1.8, positioned below its 200-day moving average of $2.1, suggesting bearish momentum. The stock has a 52-week range of $1.41 to $4.34.
Technical Analysis: The 50-day moving average stands at $2.87, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 34.553, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.338, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GANX at 51.0/100 with a HOLD recommendation.
GANX (Gain Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 34.553 |
| CMF (20) | -0.338 |
| ROC (10) | -4.255 |
| ADX (14) | 42.872 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.275 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -90.909 |
| MFI (14) | 39.732 |
GANX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GANX Price vs Max Options Open Interest
GANX Max Change In Options Open Interest
GANX Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GANX Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GANX Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GANX Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Gain Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
GANX Moving Averages Analysis
GANX (Gain Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.96 |
| 20 | 2.2 |
| 30 | 2.5 |
| 50 | 2.87 |
| 100 | 2.41 |
| 200 | 2.1 |
GANX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 75.4 million |
| Earnings/Share ($) | -0.61 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.645 |
| EPS Estimate Next Year ($) | -0.71 |
| WallStreet Target Price ($) | 7.6 |
| Most Recent Quarter |